Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pulmonary Nodules in Patients With Nonpulmonary Cancer: Not Always Metastases.
Caparica R, Mak MP, Rocha CH, Velho PHI, Viana P, Moura MRL, Menezes MR, Amato MBP, Feher O. Caparica R, et al. Among authors: rocha ch. J Glob Oncol. 2016 Feb 3;2(3):138-144. doi: 10.1200/JGO.2015.002089. eCollection 2016 Jun. J Glob Oncol. 2016. PMID: 28717693 Free PMC article.
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma.
Agache I, Song Y, Rocha C, Beltran J, Posso M, Steiner C, Alonso-Coello P, Akdis C, Akdis M, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hamelmann E, Hanania N, Mäkelä M, Martín IH, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, Pérez de Llano L, Quirce S, Sastre J, Shamji M, Schwarze J, Canelo-Aybar C, Palomares O, Jutel M. Agache I, et al. Allergy. 2020 May;75(5):1058-1068. doi: 10.1111/all.14268. Epub 2020 Apr 1. Allergy. 2020. PMID: 32154939
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Agache I, Rocha C, Beltran J, Song Y, Posso M, Solà I, Alonso-Coello P, Akdis C, Akdis M, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hamelmann E, Hanania N, Mäkelä M, Martín IH, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, Pérez de Llano L, Quirce S, Sastre J, Shamji M, Schwarze J, Canelo-Aybar C, Palomares O, Jutel M. Agache I, et al. Allergy. 2020 May;75(5):1043-1057. doi: 10.1111/all.14235. Allergy. 2020. PMID: 32064642
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Agache I, Beltran J, Akdis C, Akdis M, Canelo-Aybar C, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hamelmann E, Hanania N, Mäkelä M, Hernández-Martín I, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, Pérez de Llano L, Posso M, Rocha C, Quirce S, Sastre J, Shamji M, Song Y, Steiner C, Schwarze J, Alonso-Coello P, Palomares O, Jutel M. Agache I, et al. Allergy. 2020 May;75(5):1023-1042. doi: 10.1111/all.14221. Epub 2020 Feb 24. Allergy. 2020. PMID: 32034960
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines.
Agache I, Song Y, Posso M, Alonso-Coello P, Rocha C, Solà I, Beltran J, Akdis CA, Akdis M, Brockow K, Chivato T, Del Giacco S, Eiwegger T, Eyerich K, Giménez-Arnau A, Gutermuth J, Guttman-Yassky E, Maurer M, Ogg G, Ong PY, O'Mahony L, Schwarze J, Werfel T, Canelo-Aybar C, Palomares O, Jutel M. Agache I, et al. Allergy. 2021 Jan;76(1):45-58. doi: 10.1111/all.14510. Epub 2020 Oct 4. Allergy. 2021. PMID: 32691892
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines.
Agache I, Rocha C, Pereira A, Song Y, Alonso-Coello P, Solà I, Beltran J, Posso M, Akdis CA, Akdis M, Brockow K, Chivato T, Del Giacco S, Eiwegger T, Eyerich K, Giménez-Arnau A, Gutermuth J, Guttman-Yassky E, Maurer M, Ogg G, Ong P, O'Mahony L, Schwarze J, Werfel T, Canelo-Aybar C, Palomares O, Jutel M. Agache I, et al. Allergy. 2021 Jan;76(1):59-70. doi: 10.1111/all.14547. Epub 2020 Sep 7. Allergy. 2021. PMID: 32767573
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines.
Agache I, Song Y, Alonso-Coello P, Vogel Y, Rocha C, Solà I, Santero M, Akdis CA, Akdis M, Canonica GW, Chivato T, Del Giacco S, Eiwegger T, Fokkens W, Georgalas C, Gevaert P, Hopkins C, Klimek L, Lund V, Naclerio R, O'Mahony L, Palkonen S, Pfaar O, Schwarze J, Soyka MB, Wang Y, Zhang L, Canelo-Aybar C, Palomares O, Jutel M. Agache I, et al. Allergy. 2021 Aug;76(8):2337-2353. doi: 10.1111/all.14809. Epub 2021 Mar 24. Allergy. 2021. PMID: 33683704
Using a Taxonomy to Systematically Identify and Describe Self-Management Interventions Components in Randomized Trials for COPD.
Heijmans M, Poortvliet R, Van der Gaag M, González-González AI, Beltran Puerta J, Canelo-Aybar C, Valli C, Ballester M, Rocha C, Garcia ML, Salas-Gama K, Kaloteraki C, Santero M, Niño de Guzmán E, Spoiala C, Gurung P, Moaddine S, Willemen F, Cools I, Bleeker J, Kancheva A, Ertl J, Laure T, Kancheva I, Pacheco-Barrios K, Zafra-Tanaka J, Mavridis D, Angeliki Veroniki A, Zevgiti S, Seitidis G, Alonso-Coello P, Groene O, Sunol R, Orrego C. Heijmans M, et al. Int J Environ Res Public Health. 2022 Oct 4;19(19):12685. doi: 10.3390/ijerph191912685. Int J Environ Res Public Health. 2022. PMID: 36231985 Free PMC article.
n -butanol fraction of Terminalia catappa possesses anti-Candida albicans properties and in vivo action on Tenebrio molitor alternative infection model.
Rocha FMG, Rocha CHL, Silva LCN, Pinheiro AJMCR, Mendonça AMS, Cantanhede Filho AJ, Sousa EM, Rocha CQ, Assuncao Holanda R, Santos JRA, Monteiro CA. Rocha FMG, et al. Among authors: rocha chl. Microb Pathog. 2025 Jan;198:107133. doi: 10.1016/j.micpath.2024.107133. Epub 2024 Nov 19. Microb Pathog. 2025. PMID: 39571833
Moderate physical exercise and ATP modulate the P2X7 receptor and improve cisplatin-induced gastric emptying delay in rats.
Gomes YA, Santos WLL, Pinheiro CS, Severo JS, Oliveira Júnior JCC, da Silva ACA, Dos Santos BLB, Rocha CHL, Dos Santos AA, da Silva MTB. Gomes YA, et al. Among authors: rocha chl. Braz J Med Biol Res. 2024 May 3;57:e13234. doi: 10.1590/1414-431X2024e13234. eCollection 2024. Braz J Med Biol Res. 2024. PMID: 38716980 Free PMC article.
30 results